본문 바로가기 주메뉴 바로가기

ISV 아시아지부 미팅 소개

국제백신학회(ISV, International Society for Vaccines)는 전문적이고 학문적인 학회를 발전시켜 백신의 모든 분야에 전념할 수 있도록 해야 한다는 백신 분야의 여러 과학자들의 제안에 따라 1992년 설립되었다. 약 30년이 지난 현재, 국제백신학회는 세계 백신 분야에서 가장 널리 인정받는 비영리단체 가운데 하나이다. 국제백신학회가 지난 수 년간 외연적 성장을 하였으나, 인간과 동물에 대한 감염병 및 비감염병의 예방과 통제를 위한 백신의 개발과 사용을 장려, 확립, 증진하고자 하는 원대한 목표는 변치 않았다.

 

국제백신학회는 백신과 관련된 모든 영역에서 다양한 회원들의 전문적인 목표에 참여, 지원, 뒷받침한다. 국제백신학회는 학회의 목표와 목적을 고취하기 위해 적극적으로 지원하는 이들에게 회원 특전을 제공한다. 국제백신학회는 매년 10월 연례 총회를 개최한다. 이 총회는 백신과 관련된 세계 최대 규모의 비영리 과학 컨퍼런스이며, 백신접종 및 면역치료와 관련된 다양한 주제들을 다룬다. 국제백신학회 총회는 이 분야의 최신 발전상에 대해 듣고, 도전과제와 기회를 논의하며, 교류하기 위하여 전 세계 백신 분야의 모든 영역의 참석자들이 모이는 자리이다.

ISV 아시아지부 미팅 프로그램

ISV 아시아지부 미팅 프로그램 안내
일자 시간 내용 연사
Day 2
11.16
(금)
08:00 ~ 08:05 Opening remarks Joon Haeng Rhee
08:05 ~ 09:20 Viral vaccines
08:05 ~ 08:20 Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein Linqi Zhang
08:20 ~ 08:35 Immunogenic study of an enterovirus type 71 and coxsackievirus A 16 inactivated vaccine based on mechanistic analysis of activated innate lymphoid cells and dendritic cells Qihan Li
08:35 ~ 08:50 Development of a broadly protective vaccine against hand, foot, and mouth disease Zhong Huang
08:50 ~ 09:05 Dengue NS1: a Key Factor for Virus Transfer from Host to Mosquito Vector Gong Cheng
09:05 ~ 09:20 Efficacy and safety of an E. coli-produced human papillomavirus vaccine (types 16 and 18) Jun Zhang
09:30 ~ 10:00 Plenary Lecture
09:30 ~ 10:00 Iterative optimization by structure-based vaccine design Peter Kwong
10:05 ~ 11:25 Adjuvant and Delivery I
10:05 ~ 10:25 The Adjuvant Database for preclinical evaluation of vaccines and immunotherapy agents Ken Ishii
10:25 ~ 10:40 Immunological mechanism of synergistic anti-cancer activities by activation of TLR9 and STING Burcu Temizoz
10:40 ~ 10:55 Intrinsic MyD88 signalling in B cells controls IFNγ-mediated early IgG2c class switching in response to a particulate adjuvant Michelle S.J. Lee
10:55 ~ 11:10 The mode of action by which hydroxypropyl-β-cyclodexrin (HP-β-CD) functions as a vaccine adjuvant Takato Kusakabe
11:10 ~ 11:25 A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases Shee Eun Lee
11:35 ~ 12:35 Influenza Vaccine I
11:35 ~ 11:50 Rational design of site-specific glycan-masking and glycan-unmasking HA antigens for influenza vaccines Suh-chin Wu
11:50 ~ 12:05 Modifying hemagglutinin glycosylation in candidate vaccine virus shows the cross-reactivity against influenza viruses Manseong Park
12:05 ~ 12:20 Advancing Cross-protection of Influenza Vaccines by Virus-Like Particle Technology Pei-Wen Hsiao
12:20 ~ 12:35 A Replicating Adenovirus-Influenza H5 Vaccine Induces Prolonged Evolution of the Memory B Cell Response Jinghe Huang
12:35 ~ 13:30 Lunch (55')
13:30 ~ 14:30 Bacterial Vaccines
13:30 ~ 13:45 Injection route is an important factor for immunization of D-Ala and D-Glu auxotrophic Staphylococcus aureus mutants in the murine model Bok Leul Lee
13:45 ~ 14:00 Development of scrub typhus vaccine providing broad genotype protection Nam-Hyuk Cho
14:00 ~ 14:15 Effective prime-boost immunization against tuberculosis with heterologous viral vectors Hye Sook Jeong
14:15 ~ 14:30 Use of High-Energy Radiation to Develop Efficient Inactivated and Attenuated Vaccines Ho Seong Seo
14:40 ~ 15:00 Vaccine Science
14:40 ~ 15:00 Antigen specific Treg cell is a gatekeeper against anti-viral and anti-tumor responses—thinking ahead for vaccine design Bin Wang
15:00 ~ 15:15 Comparative analysis of whole-organ and organism-specific adjuvant transcriptomes in a systems vaccinology approach Lokesh P. Tripathi
15:15 ~ 15:30 PD1-based Vaccine Potentiates Host Immunity for HIV-1 Functional Cure Zhiwei Chen
15:30 ~ 15:45 Research Progress on Chinese Therapeutic Hypertensive Vaccine Yu-Hua Liao
15:55 ~ 17:10 Adjuvant and Delivery II
15:55 ~ 16:10 Necroptoic cell death governs neutrophil-mediated inflammation in influenza virus infection via IL-1 alpha Masatoshi Momota
16:10 ~ 16:25 Enhanced protective effect of influenza split vaccination by the combination of DAMP-inducing and PAMP adjuvants Tomoya Hayashi
16:25 ~ 16:40 Molecular interaction between IL-1 alpha and genomic DNA released by Alum-induced cell death Kou Hioki
16:40 ~ 16:55 Material-based High-performance Vaccines Potentiate Antitumor Therapy Wei Wei
16:55 ~ 17:10 Improved intradermal vaccination using coated microneedle Yeu-Chun Kim
17:10 ~ 18:20 Influenza Vaccine II
17:20 ~ 17:35 Influenza vaccine and antibody dependent cellular cytotoxicity Che Alex Ma
17:35 ~ 17:50 A monoclonal antibody-based immunoassay for measuring the potency of seasonal flu vaccines Juine Ruey Chen
17:50 ~ 18:05 Protective immune responses during H7N9 infection and vaccine development Jianqing Xu
18:05 ~ 18:20 Towards Universal Influenza Vaccine: Pan-influenza A Protection by X-31 Cold-adapted Live Attenuated Vaccine Baik Lin Seong

ISV 아시아지부 미팅 포스터 발표 안내

포스터 발표 참가 희망자는 사무국 이메일(office@hivf.org)로 초록을 접수해주시기 바랍니다.

1. 일시

2018년 11월 16일(금) 09:00 – 18:00

2. 장소

화순하니움스포츠센터 지하2층 갤러리

3. 규격 및 제작

  • - 포스터는 발표자가 직접 준비합니다.
  • - 포스터 제작 크기는 폭 0.9m X 세로 1.2m 입니다. (세로형태)
  • - 포스터 반입시간: 2018년 11월 16일 07:00~08:00
  • - 포스터 철거시간: 2018년 11월 16일 18:00~19:00
  • 포스터 반입 및 철거시간은 추후 변경될 수 있습니다.

4. 기타

포스터 발표자는 사전등록을 꼭 신청해야 합니다.

초청연사

ISV 아시아지부 미팅 초청연사 성명, 국적, 소속
성명 국적 소속
Peter Kwong USA Structural Bioinformatics Core Vaccine Research Center, NIAID
Juine Ruey Chen Taiwan RH Biopharma
Zhiwei Chen Hong Kong The University of Hong Kong Li Ka Shing Faculty of Medicine
Gong Cheng China Tsinghua University School of Medicine
조남혁(Nam-Hyuk Cho) Korea Seoul National University
Tomoya Hayashi Japan National Institutes of Biomedical innovation, Health and Nutition
Kou Hioki Japan National Institutes of Biomedical innovation, Health and Nutition
Saori Hodokami Japan National Institutes of Biomedical innovation, Health and Nutition
Pei-Wen Hsiao Taiwan Agricultural Biotechnology Research Center
Jinghe Huang China School of Basic Medical Sciences, Fudan University
Zhong Huang China Shanghai Pasteur Institute
Ken Ishii Japan National Institutes of Biomedical innovation, Health and Nutition
정혜숙(Hye Sook Jeong) Korea KCDC
김유천(Yeu-Chun Kim) Korea KAIST
Takato Kusakabe Japan National Institutes of Biomedical innovation, Health and Nutition
Michelle Lee Malaysia Osaka University
이복률(Bok Luel Lee) Korea Pusan National University
이시은(Shee Eun Lee) Korea Jeonnam National University
Qihan Li China Institute of Medical Biology, Chinese Academy of Medical Science, Peking Union Medical College
Yu-Hua Liao China "Institute Of Cardiology, Wuhan Huazhong University Of Science and Technology"
Che Alex Ma Taiwan Genomics Research Center, Academia Sinica
Masatoshi Momota Japan National Institutes of Biomedical innovation, Health and Nutition
박만성(Manseong Park) Korea Korea university
서호성(Ho Seong Seo) Korea Yonsei University
성백린(Baik L. Seong) Korea Korea Atomic Energy Research Institute
Burcu Temizoz Turkey Osaka University
Lokesh Tripathi India National Institutes of Biomedical innovation, Health and Nutition
Bin Wang China Fudan University Shanghai Medical College
Wei Wei China Institute of Process Engineering, Chinese Academy of Sciences
Suh-Chin Wu Taiwan National Tsing Hua University
Jianqing Xu China Shanghai Public Health Clinical Center
Linqi Zhang China College of Medicine, Tsinghua University
Jun Zhang China National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University